KFI
TXG icon

Key Financial Inc’s 10x Genomics TXG Stock Holding History

Key Financial Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$25 – 1510
2025
Q3 		$25 Hold
2
– – ﹤0.01% 1450
2025
Q2 		$23 Hold
2
– – ﹤0.01% 1429
2025
Q1 		$17 Hold
2
– – ﹤0.01% 1378
2024
Q4 		$29 Hold
2
– – ﹤0.01% 1376
2024
Q3 		$45 Hold
2
– – ﹤0.01% 1343
2024
Q2 		$39 Hold
2
– – ﹤0.01% 1329
2024
Q1 		$75 Hold
2
– – ﹤0.01% 1296
2023
Q4 		$112 Hold
2
– – ﹤0.01% 1290
2023
Q3 		$82 Hold
2
– – ﹤0.01% 1322
2023
Q2 		$112 Hold
2
– – ﹤0.01% 1359
2023
Q1 		$112 Hold
2
– – ﹤0.01% 1145
2022
Q4 		$57 Hold
2
– – ﹤0.01% 1162
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1182
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1165
2022
Q1 		$0 Hold
2
– – ﹤0.01% 1110
2021
Q4 		$0 Buy
+2
New +$306 ﹤0.01% 1000

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Key Financial Inc's TXG Position: Q4 2025 in Review

Key Financial Inc sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 2 shares — an estimated $25 sold.

Key Financial Inc first reported a position in TXG in Q4 2021 and held it in 16 quarters. The position peaked at $112 in Q4 2023. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Key Financial Inc reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Key Financial Inc sold 2 10x Genomics shares in Q4 2025, an estimated $25.
  • Key Financial Inc first reported a position in 10x Genomics in Q4 2021 and held it in 16 quarters.
  • Key Financial Inc's 10x Genomics position peaked at $112 in Q4 2023.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Key Financial Inc's 13F filing for Q4 2025, filed 9 Feb 2026.